Influencing factors of noninvasive positive pressure ventilation in the treatment of respiratory failure: a 10-year study in one single center

Table 2 Multivariate logistic regression analysis of the efficacy of NPPV treatment

variable	β	Standard error	Wald	P value	OR (95%CI)
Age (years)	− 0.001	0.003	0.112	0.738	0.999 (0.994–1.004)
Gender (n)	0.067	0.080	0.699	0.403	1.070 (0.914–1.252)
Analgesia and/or sedation (n)	− 0.248	0.265	0.876	0.349	0.780 (0.464–1.312)
Barotrauma (n)	0.629	0.504	1.559	0.212	1.876 (0.699–5.039)
IPAP (cmH₂O)	− 0.010	0.017	0.386	0.534	0.990 (0.958–1.023)
EPAP (cmH₂O)	0.018	0.032	0.331	0.565	1.018 (0.957–1.083)
Albumin (g/L)	0.075	0.007	117.228	0.000	1.078 (1.063–1.093)
Ca²⁺ (mmol/L)	0.031	0.043	0.523	0.469	1.032 (0.948–1.123)
Blood glucose (mmol/L)	− 0.003	0.004	0.377	0.539	0.997 (0.989–1.006)
Duration of NPPV treatment (days)	0.086	0.008	127.385	0.000	1.089 (1.073–1.106)
Length of hospital stay (days)	0.002	0.003	0.367	0.545	1.002 (0.996–1.009)

ISSN: 2047-783X